Nls pharmaceutics to participate in maxim group 2022 virtual growth conference

Zurich, switzerland / accesswire / march 25, 2022 - nls pharmaceutics ltd. (nasdaq:nlsp, nlspw) ("nls" or the "company"), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that alex zwyer, ceo and co-founder, will participate in a fireside chat at the maxim group 2022 virtual growth conference, being held march 28-30, 2022.
NLSP Ratings Summary
NLSP Quant Ranking